Abstract

Wilson's Syndrome and T3 Therapy

Author(s): Milner Martin

Issue: Sep/Oct 1999 - Natural Hormone Replacement Therapy

Page(s): 344-348

Download in electronic PDF format for $75
  • Wilson's Syndrome and T3 Therapy Page 1
  • Wilson's Syndrome and T3 Therapy Page 2
  • Wilson's Syndrome and T3 Therapy Page 3
  • Wilson's Syndrome and T3 Therapy Page 4
  • Wilson's Syndrome and T3 Therapy Page 5

Abstract

The author, a naturopathic doctor, focuses on symptoms of Wilson’s syndrome; patients most likely to be affected; diagnosis; causes of low body temperature; T3 therapy administration, regulation and monitoring; features of the 2-day compensating schedule; the patient log; thermoregulation variations; features of the 1-day compensating schedule; maximum dosing; additional benefits; hypothyroidism misconstrued as Wilson’s syndrome; cycling safely; thyroid medication and osteoporosis; contraindications; drug interactions; side effects; the value of the compounding pharmacist and slow-release T3 and prognosis. Tables provide information regarding a 2-day compensating schedule for doses of T3, a 1-day compensating schedule for doses of T3 and commonly prescribed dose increments taken as 1 capsule every 12 hours. Graphs representing sequential T3 cycles ending with improved thermal regulation after five cycles of slow-release T3 in a 51-year-old woman are provided. In addition, the author provides an algorithm for assessment and management of thermoregulation.

Related Keywords

  • adrenal insufficiency
  • adrenaline
  • anxiety
  • Coumadin
  • DHEA
  • essential fatty acids
  • estrogen
  • irritability
  • neurotensin
  • progesterone
  • T3
  • testosterone

Related Categories

  • HRT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 1999
Pg. 344-348
Wilson's Syndrome and T3 Therapy
Author(s): Milner Martin
Jul/Aug 2005
Pg. 259-264
View Sample
Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
Author(s): Tan Robert S
Jan/Feb 2013
Pg. 39-44
Adrenal Fatigue
Author(s): Allen Loyd V Jr
Sep/Oct 2012
Pg. 376-380
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Author(s): Snyder Scott, Listecki Robert E
Jul/Aug 1999
Pg. 309-310
Acidifying Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2008
Pg. 546
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Author(s): Allen Loyd V Jr
Nov/Dec 2008
Pg. 545
Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Author(s): Allen Loyd V Jr
Nov/Dec 2008
Pg. 547
Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Author(s): Allen Loyd V Jr
Nov/Dec 2008
Pg. 548
Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 418-425
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Mar/Apr 2002
Pg. 142-146
Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Author(s): Wepfer Scott T
Jan/Feb 1998
Pg. 65
Progesterone Vaginal Suppositories (Fatty Acid Base)
Author(s): Allen Loyd V Jr
Jul/Aug 2019
Pg. 325-339
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Author(s): Glaser Rebecca L, York Anne E
Jan/Feb 2024
Pg. 63
Progesterone Vaginal Suppositories (Fatty Acid Base)
Author(s): Allen Loyd V Jr
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Sep/Oct 1999
Pg. 400
Triple Estrogen 2.5-mg, Progesterone 100-mg and Testosterone 1-mg Capsules
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 238
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 190-195
Establishing a Rationale for Compounding Hormone Replacement Therapy
Author(s): Biundo Bruce
Jan/Feb 2014
Pg. 70-77
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Author(s): Ruiz Andres D, Daniels Kelly R